(MedPage Today) — Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following salvage radiotherapy (sRT) informed by prostate-specific membrane antigen (PSMA) PET/CT, a retrospective…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/119814
Author :
Publish date : 2026-02-09 22:47:00
Copyright for syndicated content belongs to the linked Source.
